ERBB2 and colorectal carcinoma: To further investigate the characteristics of the MMTV-Neu MEC cells at early and late CRC passage, we determined the proportions of progenitor and differentiated cells by FACS analysis of cell surface markers known to be expressed by tumor-initiating cells in mouse models of mammary cancer [24] or by more differentiated tumor cells [17], [25].